Profile data is unavailable for this security.
About the company
JiangXi Tianxin Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of monomeric vitamin products. The Company's business encompasses B vitamins, other vitamins, and fine chemicals. The Company's main products include vitamin B6, vitamin B1, biotin, folic acid, vitamin B5, vitamin D3, ascorbyl palmitate, vitamin E powder, vitamin A and other products. The Company's fine chemicals mainly include alpha-acetyl-gamma-butyrolactone (ABL), cholesterol, sodium methoxide, and L-alanine. The Company's products are mainly used in the fields of feed, medicine and food. The Company mainly conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)2.23bn
- Net income in CNY617.04m
- Incorporated2004
- Employees2.68k
- LocationJiangXi Tianxin Pharmaceutical Co LtdLe'anjiang Industrial Park, Leping CityJINGDEZHEN 333300ChinaCHN
- Phone+86 7 986709288
- Fax+86 7 986702388
- Websitehttp://www.txpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 11.01bn | 470.00 | 170.94 | 11.47 | -- | 15.52 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Shanghai Yizhong Pharmaceutical Co Ltd | 247.05m | 22.96m | 11.02bn | 65.00 | 471.02 | 7.54 | -- | 44.60 | 0.1132 | 0.1132 | 1.22 | 7.07 | 0.163 | 0.9556 | 2.26 | 3,800,801.00 | 1.51 | 5.44 | 1.58 | 5.64 | 81.39 | 92.99 | 9.30 | 36.90 | 7.84 | -- | 0.00 | 32.30 | -51.83 | -- | -95.68 | -- | 10.96 | -- |
| Cansino Biologics Inc | 971.83m | -142.03m | 11.23bn | 1.11k | -- | 2.99 | -- | 11.55 | -0.5455 | -0.5455 | 3.92 | 21.37 | 0.1271 | 0.5861 | 1.38 | 879,482.50 | -1.86 | -4.08 | -2.29 | -5.38 | 78.80 | 45.31 | -14.62 | -27.51 | 3.29 | -- | 0.2242 | -- | 137.01 | 226.43 | 74.45 | -- | 31.38 | -- |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.58bn | 687.99m | 11.23bn | 8.26k | 16.62 | 1.58 | -- | 1.71 | 0.2665 | 0.2665 | 2.54 | 2.80 | 0.6617 | 2.57 | 4.70 | 796,529.00 | 7.13 | 8.51 | 9.65 | 12.74 | 51.88 | 58.64 | 10.77 | 14.12 | 1.38 | -- | 0.0532 | 41.54 | -3.23 | -0.7594 | 5.21 | -- | 1.57 | -- |
| Chengdu Easton Biopharmaceuticals Co Ltd | 1.33bn | 241.37m | 11.37bn | 1.52k | 46.91 | 3.97 | -- | 8.55 | 1.37 | 1.37 | 7.55 | 16.23 | 0.3809 | 1.83 | 5.89 | 873,161.50 | 6.92 | 8.09 | 8.44 | 9.82 | 71.90 | 81.72 | 18.16 | 20.10 | 3.12 | -- | 0.0444 | 30.37 | 20.82 | 7.34 | 5.15 | 17.01 | 4.24 | -- |
| Mayinglong Pharmaceutical Group Co Ltd | 3.77bn | 571.60m | 11.66bn | 2.65k | 20.39 | 2.71 | -- | 3.09 | 1.33 | 1.33 | 8.75 | 9.97 | 0.7211 | 6.23 | 11.99 | 1,421,812.00 | 11.38 | 10.77 | 13.82 | 13.35 | 46.77 | 42.40 | 15.78 | 14.39 | 4.58 | -- | 0.0226 | 37.31 | 18.85 | 6.62 | 19.14 | 7.97 | 34.47 | 18.98 |
| Jiangxi Tianxin Pharmaceutical Co Ltd | 2.23bn | 617.04m | 11.82bn | 2.68k | 19.07 | 2.47 | -- | 5.31 | 1.42 | 1.42 | 5.11 | 10.93 | 0.3973 | 2.43 | 9.65 | 830,883.10 | 11.01 | 17.10 | 11.88 | 21.16 | 43.04 | 42.99 | 27.72 | 30.12 | 4.31 | -- | 0.0721 | 24.41 | 17.35 | 1.75 | 36.85 | -2.20 | 35.06 | -- |
| Beijing Foyou Pharma Co Ltd | 3.42bn | 463.07m | 12.17bn | 3.64k | 25.71 | 3.22 | -- | 3.56 | 0.9863 | 0.9863 | 7.28 | 7.87 | 0.733 | 3.27 | 9.59 | 938,316.50 | 9.99 | 12.53 | 12.82 | 17.64 | 65.17 | 68.01 | 13.62 | 13.02 | 2.52 | -- | 0.0077 | 33.16 | 3.17 | 7.28 | -0.0188 | 17.44 | 35.29 | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.78bn | 799.61m | 12.18bn | 2.44k | 15.23 | 3.75 | -- | 3.22 | 1.41 | 1.41 | 6.67 | 5.73 | 0.711 | 1.89 | 8.06 | 1,553,625.00 | 15.08 | 11.90 | 25.52 | 18.89 | 79.26 | 74.36 | 21.21 | 16.46 | 0.9053 | -- | 0.1379 | 73.97 | 5.72 | 10.17 | 27.19 | 19.67 | 14.29 | 24.57 |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 9.84bn | 546.80m | 12.36bn | 7.99k | 21.58 | 1.45 | -- | 1.26 | 0.4778 | 0.4778 | 8.61 | 7.10 | 0.623 | 3.08 | 5.32 | 1,230,310.00 | 3.48 | 2.33 | 5.81 | 4.32 | 46.64 | 41.26 | 5.58 | 3.99 | 0.6646 | 5.33 | 0.2803 | 29.47 | -5.65 | -2.44 | 745.24 | 45.22 | -26.03 | 33.24 |
Data as of Feb 13 2026. Currency figures normalised to JiangXi Tianxin Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zheshang Fund Management Co., Ltd.as of 30 Jun 2025 | 34.70k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 29.17k | 0.01% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 12.40k | 0.00% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 10.67k | 0.00% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 3.30k | 0.00% |
| AVIC Fund Management Co. Ltd.as of 30 Jun 2025 | 2.60k | 0.00% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2025 | 1.90k | 0.00% |
| Baoying Fund Management Co., Ltd.as of 30 Jun 2025 | 1.20k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 644.00 | 0.00% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2025 | 572.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
